(Q44646952)

English

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

scientific article published on 6 November 2003

Statements

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies (English)
6 November 2003
1635-1640

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit